Related references
Note: Only part of the references are listed.Prolylcarboxypeptidase (PRCP) as a new target for obesity treatment
Zia Shariat-Madar et al.
Diabetes Metabolic Syndrome and Obesity-Targets and Therapy (2016)
Angiotensin II type 2 receptor-interacting protein prevents vascular senescence
Li-Juan Min et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2012)
Murine prolylcarboxypeptidase depletion induces vascular dysfunction with hypertension and faster arterial thrombosis
Gregory N. Adams et al.
BLOOD (2011)
Molecular mechanisms of the antagonistic action between AT(1) and AT(2) receptors
Shin-ichiro Miura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Role of Prolylcarboxypeptidase in Angiotensin II Type 2 Receptor-Mediated Bradykinin Release in Mouse Coronary Artery Endothelial Cells
Liping Zhu et al.
HYPERTENSION (2010)
INVOLVEMENT OF PROLYLCARBOXYPEPTIDASE IN THE EFFECT OF RUTAECARPINE ON THE REGRESSION OF MESENTERIC ARTERY HYPERTROPHY IN RENOVASCULAR HYPERTENSIVE RATS
Xu-Ping Qin et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2009)
The kinin B1 receptor contributes to the cardioprotective effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in mice
Jiang Xu et al.
EXPERIMENTAL PHYSIOLOGY (2009)
Angiotensin II Type 2 Receptor Antagonizes Angiotensin II Type 1 Receptor-Mediated Cardiomyocyte Autophagy
Enzo R. Porrello et al.
HYPERTENSION (2009)
Prolylcarboxypeptidase: A cardioprotective enzyme
J. Mallela et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Upregulation of prolylcarboxypeptidase (PRCP) in lipopolysaccharide (LPS) treated endothelium promotes inflammation
My-Linh Ngo et al.
JOURNAL OF INFLAMMATION-LONDON (2009)
Identification of lipopolysaccharide binding site on high molecular weight kininogen
R. Perkins et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Involvement of c-Src Tyrosine Kinase in SHP-1 Phosphatase Activation by Ang II AT2 Receptors in Rat Fetal Tissues
Sergio E. Alvarez et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
AT2 receptors: Functional relevance in cardiovascular disease
Emma S. Jones et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Potentiation of the antihypertensive action of losartan by peripheral overexpression of the ANG II type 2 receptor
Hongwei Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Angiotensin II-induced neural differentiation via angiotensin II type 2 (AT2) receptor-MMS2 cascade involving interaction between AT2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1
Jian-Mei Li et al.
MOLECULAR ENDOCRINOLOGY (2007)
Prolylcarboxypeptidase gene, chronic hypertension, and risk of preeclampsia
Lin Wang et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2006)
Isolation and characterization of coronary endothelial and smooth muscle cells from A1 adenosine receptor-knockout mice
BY Teng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Overexpression of prolylcarboxypeptidase enhances plasma prekallikrein activation on Chinese hamster ovary cells
Z Shariat-Madar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Role of angiotensin II type 2 receptors and kinins in the cardioprotective effect of angiotensin II type 1 receptor antagonists in rats with heart failure
YH Liu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Nitric oxide mediates benefits of angiotensin II type 2 receptor overexpression during post-infarct remodeling
CM Bove et al.
HYPERTENSION (2004)
Regulation of inhibitory protein-κB and monocyte chemoattractant protein-1 by angiotensin II type 2 receptor-activated src homology protein tyrosine phosphatase-1 in fetal vascular smooth muscle cells
L Wu et al.
MOLECULAR ENDOCRINOLOGY (2004)
Recombinant prolylcarboxypeptidase activates plasma prekallikrein
Z Shariat-Madar et al.
BLOOD (2004)
The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling
BG Neel et al.
TRENDS IN BIOCHEMICAL SCIENCES (2003)
Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis
S Kurisu et al.
HYPERTENSION (2003)
Role of AT2 receptors in the cardioprotective effect of AT1 antagonists in mice
J Xu et al.
HYPERTENSION (2002)
Identification of prolylcarboxypeptidase as the cell matrix-associated prekallikrein activator
CR Moreira et al.
FEBS LETTERS (2002)
Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator
Z Shariat-Madar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Angiotensin II type 2 receptor inhibits epidermal growth factor receptor transactivation by increasing association of SHP-1 tyrosine phosphatase
Y Shibasaki et al.
HYPERTENSION (2001)
Angiotensin and its AT2 receptor:: new insights into an old system
M Stoll et al.
REGULATORY PEPTIDES (2001)
Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B2 kinin receptor gene knockout mice
XP Yang et al.
CIRCULATION RESEARCH (2001)
Assembly and activation of HK-PK complex on endothelial cells results in bradykinin liberation and NO formation
YQ Zhao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2001)
Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell
TX Cui et al.
CARDIOVASCULAR RESEARCH (2001)
Differential role of angiotensin II receptor subtypes on endothelial superoxide formation
HY Sohn et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
